Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients

In patients with schizophrenia receiving polypharmacy, switching to monotherapy resulted in improvements in attention. Furthermore, improvements in executive function led to improvements in daily living, and improvements in attention led to improvements in work skills. Thus, switching to monotherapy is a useful option.